MetaCap

Amylyx Pharmaceuticals (AMLX) News

NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.02-0.18 (-0.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AMLX news summary

We found 6 recent headlines mentioning Amylyx Pharmaceuticals (AMLX): 1 in the past week and 5 in the past 30 days, most often from Nasdaq, Business Wire, Seeking Alpha. For price context, AMLX is down 0.69% at $26.02. The most recent story, "Amylyx's Avexitide Cuts Low Blood Sugar Events By 55% In Phase 3 Trial; FDA Filing Due Year-End", was published by Nasdaq on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Amylyx Pharmaceuticals headlines

Stocks mentioned alongside AMLX

Compare AMLX